This page may have documents that can’t be read by screen reader software. For help with these documents, please call 1-800-975-6314.
Applies to Group, Retail, Medicare Markets
On Dec. 2, President Biden announced that his administration would issue guidance by early 2022 about coverage of over-the-counter COVID-19 diagnostic tests.
What this means. The announcement provides little detail about the changes. The guidance will need to answer critical questions about what will be expected from insurers and health plans. Once released, we will evaluate the guidance to determine how it affects our current COVID-19 testing coverage and provide any applicable updates.
While we provide information about federal guidance, we do not provide groups with legal or compliance advice. Group customers must contact their legal advisors if they have questions about proposed rules and new regulations, what they will require and how they will affect their benefit plans if finalized.